press

Follow
Press releases
Acertitude Recruits Chief Technology Officer for Oncology Health Technology Pioneer Cota Healthcare Acertitude Recruits Chief Technology Officer for Oncology Health Technology Pioneer Cota Healthcare
Oct
16
2018
Back to News

Acertitude Recruits Chief Technology Officer for Oncology Health Technology Pioneer Cota Healthcare

Dynamic technology leader Bernard Chien increases breakthrough capability

NEW YORK (Oct 16, 2018) — Acertitude, the executive search firm unleashing human potential globally, has recruited Bernard Chien as chief technology officer of Cota Healthcare, a real-world data and analytics company. Effective today, the addition of Chien expands the company’s capability to deliver enabling treatment insights that improve patient outcomes and reduce the total cost of care. He joins Cota from Best Doctors, where he was also the chief technology officer.

“We are thrilled to have Bernard join our mission to enable delivery of the best possible patient outcomes, and reduce the total costs of care for populations,” said Andrew Pecora M.D., founder and executive chairman of the health technology company. “He is a very capable technology leader — strategic, innovative, and truly knows the healthcare SaaS space.”

As CTO, Chien will leverage the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by oncologists and data scientists. Cota’s breakthrough CNA system is the first and only system that precisely categorizes patient factors and intended therapies to enable precision medicine at scale. Chien’s new role includes responsibility for expanding Cota’s technology vision and development roadmap, product strategy, and leading the engineering and product teams.

“Cota is revealing breakthrough insights in oncology and healthcare in general,” said Andrew Norden, M.D., chief medical officer. “Our leadership team saw in Bernard the leadership and expertise needed to continue driving our platform into the future. We are thrilled that he is joining us.”

Chien is a dynamic technology leader with more than 20 years of experience. He spent the past eight years running technology teams in the healthcare industry. Prior to Best Doctors, he previously served as CTO of Applause, MedVentive, and Radisphere. He spent his earlier years in architect and software engineering roles at athenahealth, Intralinks, and Sapient. He earned a Bachelor of Science, Computer Science and Electrical Engineering from the Massachusetts Institute of Technology.

“I am honored to join an organization with such a powerful mission and a truly breakthrough system for medical data extraction and analysis,” said Chien. “I look forward to working with Cota’s talented team to forge additional breakthroughs that will give providers and health systems the tools they need to make better treatment decisions, and to offer life sciences companies research grade data resources to support treatment discovery and testing.”

Acertitude served as an advisor to the Cota leadership team by shaping the role and recruiting Chien in 107 days. Nate DaPore, Acertitude managing director and healthcare practice leader, led the search with support from partner Vicki Devlin and research team.

“We are honored to partner with the pioneer in oncology health technology,” DaPore said. “The combination of Bernard’s expertise and passion for the mission made him stand out as the best qualified candidate to expand Cota’s breakthrough capabilities.”

About Acertitude
Acertitude is the executive search firm unleashing human potential globally. The firm builds close client partnerships and drives an agile process to connect organizations with brilliant people at work. Acertitude serves the global executive search market across the consumer, financial, healthcare and life sciences, industrial, private equity, professional services, and technology industries. To learn more about how Acertitude places brilliant people at work, visit www.acertitude.com.

About Cota Healthcare
New York based Cota Healthcare is a real-world data and analytics company that enables providers, payers, and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. The company does this using the patented Cota Nodal Address™ (CNA) system, a unique digital classification methodology built by leading physicians and data scientists. Cota’s breakthrough CNA system is the first and only system that precisely categorizes patient factors, their diseases, and intended therapies, enabling precision medicine at scale. Earlier this year, Cota announced a $40 million Series C round of financing. www.deliveringbreakthroughinsights.com 

Media Inquiries: For additional information, please contact Linnéa Jungnelius, Acertitude Marketing Director, at linnea@acertitude.com or Camela Morrissey, Cota Head of Marketing at camelamorrissey@cotahealthcare.com.